A study for a 69 year old woman who takes Azithromycin, Januvia, Metrogel-Vaginal - from FDA reports

155 females aged 69 (┬▒5) who take the same drugs are studied. This is a personalized study for a 69 year old female patient who has Sinusitis, Diabetes, Vaginitis. The study is created by eHealthMe based on reports from FDA.

On Apr, 15, 2018

155 females aged 69 (┬▒5) who take Azithromycin, Januvia, Metrogel-Vaginal are studied.

Number of reports submitted per year:

Azithromycin, Januvia, Metrogel-Vaginal for a 69-year old woman.

Information of the patient in this study:

  • Age: 69
  • Gender: female
  • Conditions: Sinusitis, Diabetes, Vaginitis
  • Drugs taken:
    • Azithromycin (azithromycin)
    • Januvia (sitagliptin phosphate)
    • Metrogel-Vaginal (metronidazole)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  1. Skin ulcer
  2. Rashes (redness)
  3. Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
  4. Impaired healing
  5. Drug eruption (adverse drug reaction of the skin)
1 - 6 months:
  1. Hair loss
  2. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Erythema multiforme (a type of hypersensitivity reaction)
  5. Hepatic function abnormal
6 - 12 months:
  1. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
1 - 2 years:
2 - 5 years:
5 - 10 years:
10+ years:
not specified:
  1. Fatigue (feeling of tiredness)
  2. Pain
  3. Stress and anxiety
  4. Swelling
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

Top conditions involved for these people *:

  1. Multiple Myeloma (cancer of the plasma cells): 20 people, 12.90%
  2. Pain : 16 people, 10.32%
  3. Muscle Spasms (muscle contraction): 9 people, 5.81%
  4. Metastases To Bone (cancer spreads to bone): 8 people, 5.16%
  5. Breast Cancer : 8 people, 5.16%

Top co-used drugs for these people *:

  1. Levaquin (50 people, 32.26%)
  2. Zometa (47 people, 30.32%)
  3. Prednisone (46 people, 29.68%)
  4. Lyrica (38 people, 24.52%)
  5. Cymbalta (37 people, 23.87%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You are not alone: Connect with people like you, or share your experience to help people like you.

Related tests

We suggest these affordable tests for self monitoring. You can order them and receive results on eHealthMe. No doctor referral or insurance necessary.

What are the drugs?

What are the conditions?

Related studies:

Related publications that referenced our studies

You may be interested in these posts

More posts for: Azithromycin, Januvia, Metrogel-vaginal, Sinusitis, Vaginitis, Diabetes

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.